GLENN SBLENDORIO Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for GLENN SBLENDORIO.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of GLENN SBLENDORIO. GLENN SBLENDORIO is President & CFO in MEDICINES CO /DE ($MDCO) and Director in AMICUS THERAPEUTICS INC ($FOLD) and CFO, SR VP FINANCE in EYETECH PHARMACEUTICALS INC ($EYET) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in Ophthotech Corp. ($OPHT) and EVP, COO & CFO, Treasurer in Ophthotech Corp. ($OPHT) and President & CEO in IVERIC bio, Inc. ($OPHT) and President and CEO in Ophthotech Corp. ($OPHT) and President, CFO & Treasurer in Ophthotech Corp. ($OPHT) and President, CFO and Treasurer in Ophthotech Corp. ($OPHT).

GLENN SBLENDORIO in INTERCEPT PHARMACEUTICALS, INC.

Trading Symbol: ICPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GLENN SBLENDORIO: Director
Holdings: 15,710 shares
Current Value: $1,784,185
Latest Transaction: Jun 01 2021
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of GLENN SBLENDORIO in INTERCEPT PHARMACEUTICALS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, FOLD, EYET, ICPT, OPHT, MDCO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 01 2021ICPTINTERCEPT PHARMACE ...SBLENDORIO GLENNDirectorOption ExerciseA17.0812,089206,48012,089
Jun 01 2021ICPTINTERCEPT PHARMACE ...SBLENDORIO GLENNDirectorGrantA0.007,029015,7108.7 K to 15.7 K (+80.97 %)
Jun 01 2020ICPTINTERCEPT PHARMACE ...SBLENDORIO GLENNDirectorOption ExerciseA72.742,966215,7472,966
Jun 01 2020ICPTINTERCEPT PHARMACE ...SBLENDORIO GLENNDirectorGrantA0.001,59508,6817.1 K to 8.7 K (+22.51 %)
Jun 21 2019ICPTINTERCEPT PHARMACE ...SBLENDORIO GLENNDirectorOption ExerciseA82.252,174178,8122,174
Jun 21 2019ICPTINTERCEPT PHARMACE ...SBLENDORIO GLENNDirectorGrantA0.001,57007,0865.5 K to 7.1 K (+28.46 %)
Jun 22 2018ICPTINTERCEPT PHARMACE ...SBLENDORIO GLENNDirectorOption ExerciseA85.122,748233,9102,748
Jun 22 2018ICPTINTERCEPT PHARMACE ...SBLENDORIO GLENNDirectorGrantA0.001,78705,5163.7 K to 5.5 K (+47.92 %)
Jun 29 2017ICPTINTERCEPT PHARMACE ...SBLENDORIO GLENNDirectorOption ExerciseA122.012,036248,4122,036
Jun 29 2017ICPTINTERCEPT PHARMACE ...SBLENDORIO GLENNDirectorGrantA0.001,42303,7292.3 K to 3.7 K (+61.71 %)
Jul 21 2016ICPTINTERCEPT PHARMACE ...SBLENDORIO GLENNDirectorOption ExerciseA145.221,598232,0621,598
Jul 21 2016ICPTINTERCEPT PHARMACE ...SBLENDORIO GLENNDirectorGrantA0.001,20402,3061.1 K to 2.3 K (+109.26 %)
Nov 27 2015ICPTINTERCEPT PHARMACE ...SBLENDORIO GLENNDirectorOption ExerciseA183.621,750321,3351,750
Nov 27 2015ICPTINTERCEPT PHARMACE ...SBLENDORIO GLENNDirectorGrantA0.0065001,102452 to 1.1 K (+143.81 %)

Page:   1